Unprecedented experience

CTL MAT Expertise

CTL-MAT combines Cellular Technology Limited’s background in immune monitoring, that of founder and CTL-MAT co-founder Paul V Lehman with 15 years of leading MAT-specific expertise of Drs. Shabnam Solati, CTL-MAT's co-founder and CEO (see her milestone publication on the Monocyte Activation Test).

Culture & Values

At CTL-MAT, our Cultural Qualities direct our work and provide a foundation for our success. Our employees are Accountable, Collaborative, Competitive, High Performing and Trustworthy.

ACCOUNTABLE: Each team member has personal responsibility for ensuring CTL -MAT's success

COLLABORATIVE: We work together, and with external parties, to continually push the boundaries of MAT.

COMPETITIVE: We value innovative, breakthrough thinking that paves the way for industry leadership and will never cease in our pursuit of results.

HIGH PERFORMING: Simply put, we deliver on our commitments.

TRUSTWORTHY: We consistently model our values in all that we do. We are open, honest, ethical and genuine.

PASSION: We use our drive and commitment to motivate, engage and encourage others.

CTL-MAT's Mission

We aim at enabling better and ethical drug releases, without involving unnecessary animal testing.

CTL-MAT LLC is a member of the Cellular Technology Limited group that has a 20-year track record of excellence in in-vitro immune monitoring. CTL's founding scientists were the first to introduce protocols for functionality loss free cryopreservation of PBMC (see our publication), as required for MAT. CTL's founder and CEO, Prof. Paul V. Lehmann is co-founder of CTL-MAT and acts as it's Chief Scientific Officer.

CTL has since been the leading provider of cryopreserved PBMC, worldwide. CTL also pioneered in vitro cytokine detection, as required for MAT testing (see our patent) providing such test kits internationally.

CTL-MAT combines CTL's background in immune monitoring with 15 years of leading MAT-specific expertise of Drs. Shabnam Solati, CTL-MAT's co-founder and CEO (see her milestone publication on MAT).

Save crab lives!

Save rabbit lives!

Save human lives!

What We Do

CTL-MAT offers test kits for MAT that permit Ph. Eur. 2.6.30-compliant, robust and accurate detection of pyrogenic contamination of parenteral drugs, biopharmaceuticals, cosmetics and solid medical devices. See Ph. Eur. 2.6.30-requirements. CTL-MAT’s mission is to support its customers with any and all their MAT-related needs.

Please inquire if you do not find your current needs covered in CTL-MAT’s list of offerings – we may have a custom solution for you!